Search

Search results

84 results found

A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease

Kheirkhah, Ahmad, Antonio Di Zazzo, Vannarut Satitpitakul, Merle Fernandez, Daniel Magilavy, and Reza Dana. 2017. “A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease”. Cornea 36 (7): 799-804.

Joan Miller, MD, appointed to AUPO Board of Trustees

Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed driving innovation and quality in academic medicine, and strongly supports mentoring and developing...

Michael Gilmore, PhD, chairs $20 million antibiotic-resistance challenge

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of...